Cristina Vilaplana

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

Ainhoa Arbués, Jesús Gonzalo‐Asensio, Dessislava Marinova et al. · Vaccine · 2013 · 254 citations · Full text

Vaccination, Pulmonary Tuberculosis, Vaccine Development +11

Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis

Lúcia Moreira-Teixeira, Philippa J. Stimpson, Evangelos Stavropoulos et al. · Nature Communications · 2020 · 215 citations · Full text

Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis

Cristina Vilaplana, Elena Marzo, Gustavo Tapia et al. · The Journal of Infectious Diseases · 2013 · 212 citations · Full text

Tuberculosis Prevention, Immunology, Biological Therapy +18

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®

Cristina Vilaplana, Eva Montané, Sergio Pinto et al. · Vaccine · 2009 · 128 citations

Vaccinology, Vaccination, Vaccine Development +8

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Marco Schito, Giovanni Battista Migliori, Helen A. Fletcher et al. · Clinical Infectious Diseases · 2015 · 121 citations · Full text

Tuberculosis Prevention, Immunology, Diagnostics +16